AcuraStem, USC and Icagen to collaborate on fast track SBIR grant for the development of a novel small molecule therapy to treat ALS
AcuraStem, an early stage biotech company located in Los Angeles, and Justin Ichida at USC have been awarded a $3.7 million Small Business Innovation Research (SBIR) FastTrack grant by the National Institute …